Group 1 - The core viewpoint of the article highlights the significant decline in the stock price of Lepu Medical, which closed at 10.42 yuan, down 11.99%, with a rolling PE ratio of 27.71 times and a total market capitalization of 19.596 billion yuan [1] - The average PE ratio for the medical device industry is 43.33 times, with a median of 27.80 times, placing Lepu Medical at the 73rd position in the industry ranking [1] - As of September 30, 2024, Lepu Medical has 94,003 shareholders, an increase of 11,288 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Lepu Medical's main business includes medical devices, pharmaceuticals, medical services, and health management, with a strong focus on cardiovascular medical devices and leading technology in "interventional without implantation" [1] - The latest financial results for the third quarter of 2024 show that the company achieved an operating income of 4.785 billion yuan, a year-on-year decrease of 23.55%, and a net profit of 803 million yuan, down 40.70%, with a gross profit margin of 62.80% [1]
乐普医疗收盘下跌11.99%,滚动市盈率27.71倍,总市值195.96亿元